Autor: |
Araujo SE; Department of Gastroenterology, Hospital das Clínicas, Faculty of Medicine, University of São Paulo., Alves PR, Habr-Gama A |
Jazyk: |
angličtina |
Zdroj: |
Revista do Hospital das Clinicas [Rev Hosp Clin Fac Med Sao Paulo] 2001 Jan-Feb; Vol. 56 (1), pp. 25-35. |
DOI: |
10.1590/s0041-87812001000100005 |
Abstrakt: |
Colorectal cancer (CRC) represents the third most common malignancy throughout the world. Little or no improvement in survival has been effectively achieved in the last 50 years. Extensive epidemiological and genetic data are able to identify more precisely definite risk-groups so screening and early diagnosis can be more frequently accomplished. CRC is best detected by colonoscopy, which allows sampling for histologic diagnosis. Colonoscopy is the gold standard for detection of small and premalignant lesions, although it is not cost-effective for screening average-risk population. Colonoscopic polypectomy and mucosal resection constitute curative treatment for selective cases of invasive CRC. Similarly, alternative trans-colonoscopic treatment can be offered for adequate palliation, thus avoiding surgery. |
Databáze: |
MEDLINE |
Externí odkaz: |
|